Frequentist, Bayesian Analysis and Complementary Statistical Tools for Geriatric and Rehabilitation Fields: Are Traditional Null-Hypothesis Significance Testing Methods Sufficient?
Dahan da Cunha Nascimento, Nicholas Rolnick, Isabella da Silva Almeida, Gerson Cipriano Junior, João Luiz Durigan
{"title":"Frequentist, Bayesian Analysis and Complementary Statistical Tools for Geriatric and Rehabilitation Fields: Are Traditional Null-Hypothesis Significance Testing Methods Sufficient?","authors":"Dahan da Cunha Nascimento, Nicholas Rolnick, Isabella da Silva Almeida, Gerson Cipriano Junior, João Luiz Durigan","doi":"10.2147/cia.s441799","DOIUrl":null,"url":null,"abstract":"<strong>Abstract:</strong> Null hypothesis significant testing (NHST) is the dominant statistical approach in the geriatric and rehabilitation fields. However, NHST is routinely misunderstood or misused. In this case, the findings from clinical trials would be taken as evidence of no effect, when in fact, a clinically relevant question may have a “non-significant” <em>p</em>-value. Conversely, findings are considered clinically relevant when significant differences are observed between groups. To assume that <em>p</em>-value is not an exclusive indicator of an association or the existence of an effect, researchers should be encouraged to report other statistical analysis approaches as Bayesian analysis and complementary statistical tools alongside the <em>p</em>-value (eg, effect size, confidence intervals, minimal clinically important difference, and magnitude-based inference) to improve interpretation of the findings of clinical trials by presenting a more efficient and comprehensive analysis. However, the focus on Bayesian analysis and secondary statistical analyses does not mean that NHST is less important. Only that, to observe a real intervention effect, researchers should use a combination of secondary statistical analyses in conjunction with NHST or Bayesian statistical analysis to reveal what <em>p</em>-values cannot show in the geriatric and rehabilitation studies (<em>eg,</em> the clinical importance of 1kg increase in handgrip strength in the intervention group of long-lived older adults compared to a control group). This paper provides potential insights for improving the interpretation of scientific data in rehabilitation and geriatric fields by utilizing Bayesian and secondary statistical analyses to better scrutinize the results of clinical trials where a <em>p</em>-value alone may not be appropriate to determine the efficacy of an intervention.<br/><br/><strong>Keywords:</strong> statistics, statistical significance, effect size, p-value<br/>","PeriodicalId":10417,"journal":{"name":"Clinical Interventions in Aging","volume":"54 1","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Interventions in Aging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/cia.s441799","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Null hypothesis significant testing (NHST) is the dominant statistical approach in the geriatric and rehabilitation fields. However, NHST is routinely misunderstood or misused. In this case, the findings from clinical trials would be taken as evidence of no effect, when in fact, a clinically relevant question may have a “non-significant” p-value. Conversely, findings are considered clinically relevant when significant differences are observed between groups. To assume that p-value is not an exclusive indicator of an association or the existence of an effect, researchers should be encouraged to report other statistical analysis approaches as Bayesian analysis and complementary statistical tools alongside the p-value (eg, effect size, confidence intervals, minimal clinically important difference, and magnitude-based inference) to improve interpretation of the findings of clinical trials by presenting a more efficient and comprehensive analysis. However, the focus on Bayesian analysis and secondary statistical analyses does not mean that NHST is less important. Only that, to observe a real intervention effect, researchers should use a combination of secondary statistical analyses in conjunction with NHST or Bayesian statistical analysis to reveal what p-values cannot show in the geriatric and rehabilitation studies (eg, the clinical importance of 1kg increase in handgrip strength in the intervention group of long-lived older adults compared to a control group). This paper provides potential insights for improving the interpretation of scientific data in rehabilitation and geriatric fields by utilizing Bayesian and secondary statistical analyses to better scrutinize the results of clinical trials where a p-value alone may not be appropriate to determine the efficacy of an intervention.
摘要:零假设显著性检验(NHST)是老年医学和康复领域的主要统计方法。然而,NHST 经常被误解或误用。在这种情况下,临床试验结果会被视为无影响的证据,而事实上,与临床相关的问题可能只有 "不显著 "的 p 值。相反,当观察到组间存在显著差异时,研究结果才被视为与临床相关。假设 p 值不是关联或效应存在的唯一指标,则应鼓励研究人员在报告 p 值的同时报告其他统计分析方法,如贝叶斯分析和补充统计工具(如效应大小、置信区间、最小临床重要性差异和基于幅度的推断),以通过更有效、更全面的分析来改进对临床试验结果的解释。然而,关注贝叶斯分析和二次统计分析并不意味着 NHST 就不那么重要。只是,为了观察到真正的干预效果,研究人员应将二次统计分析与 NHST 或贝叶斯统计分析结合起来使用,以揭示老年医学和康复研究中 p 值无法显示的内容(例如,与对照组相比,干预组长寿老年人手握力增加 1 千克的临床重要性)。本文通过利用贝叶斯和二次统计分析来更好地审查临床试验的结果,为改进康复和老年医学领域科学数据的解释提供了潜在的见解,在临床试验中,仅用 p 值来确定干预措施的疗效可能并不合适。
期刊介绍:
Clinical Interventions in Aging, is an online, peer reviewed, open access journal focusing on concise rapid reporting of original research and reviews in aging. Special attention will be given to papers reporting on actual or potential clinical applications leading to improved prevention or treatment of disease or a greater understanding of pathological processes that result from maladaptive changes in the body associated with aging. This journal is directed at a wide array of scientists, engineers, pharmacists, pharmacologists and clinical specialists wishing to maintain an up to date knowledge of this exciting and emerging field.